Logo image of CTVA

CORTEVA INC (CTVA) Stock Fundamental Analysis

NYSE:CTVA - New York Stock Exchange, Inc. - US22052L1044 - Common Stock

63.12  +0.8 (+1.28%)

After market: 63.12 0 (0%)

Fundamental Rating

5

Overall CTVA gets a fundamental rating of 5 out of 10. We evaluated CTVA against 85 industry peers in the Chemicals industry. CTVA has only an average score on both its financial health and profitability. CTVA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CTVA was profitable.
In the past year CTVA had a positive cash flow from operations.
CTVA had positive earnings in 4 of the past 5 years.
CTVA had a positive operating cash flow in each of the past 5 years.
CTVA Yearly Net Income VS EBIT VS OCF VS FCFCTVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B -4B

1.2 Ratios

CTVA has a Return On Assets of 1.66%. This is comparable to the rest of the industry: CTVA outperforms 45.78% of its industry peers.
The Return On Equity of CTVA (2.81%) is comparable to the rest of the industry.
CTVA's Return On Invested Capital of 4.85% is in line compared to the rest of the industry. CTVA outperforms 55.42% of its industry peers.
CTVA had an Average Return On Invested Capital over the past 3 years of 4.72%. This is in line with the industry average of 6.57%.
The 3 year average ROIC (4.72%) for CTVA is below the current ROIC(4.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.66%
ROE 2.81%
ROIC 4.85%
ROA(3y)2.85%
ROA(5y)1.58%
ROE(3y)4.8%
ROE(5y)2.64%
ROIC(3y)4.72%
ROIC(5y)3.55%
CTVA Yearly ROA, ROE, ROICCTVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 -4 6 -6

1.3 Margins

CTVA's Profit Margin of 4.18% is in line compared to the rest of the industry. CTVA outperforms 54.22% of its industry peers.
In the last couple of years the Profit Margin of CTVA has declined.
Looking at the Operating Margin, with a value of 11.73%, CTVA is in the better half of the industry, outperforming 63.86% of the companies in the same industry.
CTVA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 43.51%, CTVA belongs to the top of the industry, outperforming 87.95% of the companies in the same industry.
In the last couple of years the Gross Margin of CTVA has grown nicely.
Industry RankSector Rank
OM 11.73%
PM (TTM) 4.18%
GM 43.51%
OM growth 3Y27.36%
OM growth 5YN/A
PM growth 3Y-3.78%
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y6.91%
CTVA Yearly Profit, Operating, Gross MarginsCTVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

5

2. Health

2.1 Basic Checks

CTVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CTVA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CTVA has been reduced compared to 5 years ago.
The debt/assets ratio for CTVA is higher compared to a year ago.
CTVA Yearly Shares OutstandingCTVA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 200M 400M 600M
CTVA Yearly Total Debt VS Total AssetsCTVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B 100B

2.2 Solvency

CTVA has an Altman-Z score of 2.20. This is not the best score and indicates that CTVA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.20, CTVA is doing good in the industry, outperforming 61.45% of the companies in the same industry.
The Debt to FCF ratio of CTVA is 3.27, which is a good value as it means it would take CTVA, 3.27 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CTVA (3.27) is better than 84.34% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that CTVA is not too dependend on debt financing.
CTVA's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. CTVA outperforms 78.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Altman-Z 2.2
ROIC/WACC0.52
WACC9.31%
CTVA Yearly LT Debt VS Equity VS FCFCTVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20B 40B 60B

2.3 Liquidity

CTVA has a Current Ratio of 1.50. This is a normal value and indicates that CTVA is financially healthy and should not expect problems in meeting its short term obligations.
CTVA has a Current ratio of 1.50. This is in the lower half of the industry: CTVA underperforms 69.88% of its industry peers.
A Quick Ratio of 0.96 indicates that CTVA may have some problems paying its short term obligations.
CTVA has a Quick ratio of 0.96. This is in the lower half of the industry: CTVA underperforms 69.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 0.96
CTVA Yearly Current Assets VS Current LiabilitesCTVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

3

3. Growth

3.1 Past

CTVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.52%.
The Earnings Per Share has been growing by 21.34% on average over the past years. This is a very strong growth
The Revenue has decreased by -4.08% in the past year.
CTVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.81% yearly.
EPS 1Y (TTM)-11.52%
EPS 3Y21.34%
EPS 5YN/A
EPS Q2Q%-113.04%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y6.61%
Revenue growth 5Y3.81%
Sales Q2Q%-10.19%

3.2 Future

Based on estimates for the next years, CTVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.28% on average per year.
Based on estimates for the next years, CTVA will show a small growth in Revenue. The Revenue will grow by 2.15% on average per year.
EPS Next Y-2.38%
EPS Next 2Y10.05%
EPS Next 3Y11.33%
EPS Next 5Y8.28%
Revenue Next Year-0.77%
Revenue Next 2Y0.71%
Revenue Next 3Y1.74%
Revenue Next 5Y2.15%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTVA Yearly Revenue VS EstimatesCTVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
CTVA Yearly EPS VS EstimatesCTVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.52, CTVA can be considered very expensive at the moment.
CTVA's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CTVA to the average of the S&P500 Index (28.29), we can say CTVA is valued inline with the index average.
CTVA is valuated rather expensively with a Price/Forward Earnings ratio of 19.45.
CTVA's Price/Forward Earnings ratio is in line with the industry average.
CTVA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.44.
Industry RankSector Rank
PE 26.52
Fwd PE 19.45
CTVA Price Earnings VS Forward Price EarningsCTVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CTVA's Enterprise Value to EBITDA ratio is in line with the industry average.
CTVA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.85
EV/EBITDA 13.49
CTVA Per share dataCTVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of CTVA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.05%
EPS Next 3Y11.33%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.10%, CTVA has a reasonable but not impressive dividend return.
CTVA's Dividend Yield is comparable with the industry average which is at 3.26.
Compared to an average S&P500 Dividend Yield of 2.28, CTVA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

On average, the dividend of CTVA grows each year by 30.66%, which is quite nice.
CTVA has been paying a dividend for over 5 years, so it has already some track record.
As CTVA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)30.66%
Div Incr Years5
Div Non Decr Years5
CTVA Yearly Dividends per shareCTVA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

65.04% of the earnings are spent on dividend by CTVA. This is not a sustainable payout ratio.
CTVA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP65.04%
EPS Next 2Y10.05%
EPS Next 3Y11.33%
CTVA Yearly Income VS Free CF VS DividendCTVA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B -4B
CTVA Dividend Payout.CTVA Dividend Payout, showing the Payout Ratio.CTVA Dividend Payout.PayoutRetained Earnings

CORTEVA INC

NYSE:CTVA (1/21/2025, 8:04:00 PM)

After market: 63.12 0 (0%)

63.12

+0.8 (+1.28%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners84.86%
Inst Owner Change-0.21%
Ins Owners0.09%
Ins Owner Change2.87%
Market Cap43.38B
Analysts79.33
Price Target66.85 (5.91%)
Short Float %1.64%
Short Ratio3.22
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly Dividend0.62
Dividend Growth(5Y)30.66%
DP65.04%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-28.58%
Min EPS beat(2)-61.17%
Max EPS beat(2)4.01%
EPS beat(4)3
Avg EPS beat(4)24.66%
Min EPS beat(4)-61.17%
Max EPS beat(4)152.12%
EPS beat(8)6
Avg EPS beat(8)41.12%
EPS beat(12)9
Avg EPS beat(12)32.92%
EPS beat(16)13
Avg EPS beat(16)40.84%
Revenue beat(2)0
Avg Revenue beat(2)-9.08%
Min Revenue beat(2)-15.45%
Max Revenue beat(2)-2.71%
Revenue beat(4)1
Avg Revenue beat(4)-5.73%
Min Revenue beat(4)-15.45%
Max Revenue beat(4)0.46%
Revenue beat(8)2
Avg Revenue beat(8)-4.41%
Revenue beat(12)5
Avg Revenue beat(12)-2.54%
Revenue beat(16)9
Avg Revenue beat(16)0.05%
PT rev (1m)0.63%
PT rev (3m)3.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)24.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.87%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE 26.52
Fwd PE 19.45
P/S 2.61
P/FCF 24.85
P/OCF 18.5
P/B 1.75
P/tB 8.63
EV/EBITDA 13.49
EPS(TTM)2.38
EY3.77%
EPS(NY)3.25
Fwd EY5.14%
FCF(TTM)2.54
FCFY4.02%
OCF(TTM)3.41
OCFY5.41%
SpS24.21
BVpS35.99
TBVpS7.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.66%
ROE 2.81%
ROCE 6.2%
ROIC 4.85%
ROICexc 5.23%
ROICexgc 13.66%
OM 11.73%
PM (TTM) 4.18%
GM 43.51%
FCFM 10.49%
ROA(3y)2.85%
ROA(5y)1.58%
ROE(3y)4.8%
ROE(5y)2.64%
ROIC(3y)4.72%
ROIC(5y)3.55%
ROICexc(3y)5.28%
ROICexc(5y)3.95%
ROICexgc(3y)16.84%
ROICexgc(5y)12.59%
ROCE(3y)5.51%
ROCE(5y)4.14%
ROICexcg growth 3Y34.24%
ROICexcg growth 5YN/A
ROICexc growth 3Y36.47%
ROICexc growth 5YN/A
OM growth 3Y27.36%
OM growth 5YN/A
PM growth 3Y-3.78%
PM growth 5YN/A
GM growth 3Y1.83%
GM growth 5Y6.91%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Debt/EBITDA 1.55
Cap/Depr 48.42%
Cap/Sales 3.6%
Interest Coverage 250
Cash Conversion 73.53%
Profit Quality 251.22%
Current Ratio 1.5
Quick Ratio 0.96
Altman-Z 2.2
F-Score6
WACC9.31%
ROIC/WACC0.52
Cap/Depr(3y)48.23%
Cap/Depr(5y)51.56%
Cap/Sales(3y)3.53%
Cap/Sales(5y)4.46%
Profit Quality(3y)101.82%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.52%
EPS 3Y21.34%
EPS 5YN/A
EPS Q2Q%-113.04%
EPS Next Y-2.38%
EPS Next 2Y10.05%
EPS Next 3Y11.33%
EPS Next 5Y8.28%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y6.61%
Revenue growth 5Y3.81%
Sales Q2Q%-10.19%
Revenue Next Year-0.77%
Revenue Next 2Y0.71%
Revenue Next 3Y1.74%
Revenue Next 5Y2.15%
EBIT growth 1Y-6.2%
EBIT growth 3Y35.77%
EBIT growth 5YN/A
EBIT Next Year48.55%
EBIT Next 3Y21.96%
EBIT Next 5Y14.64%
FCF growth 1Y123.85%
FCF growth 3Y-9.6%
FCF growth 5YN/A
OCF growth 1Y67.5%
OCF growth 3Y-5.01%
OCF growth 5Y29.65%